A new drug has been shown to improve the brain function of people with early stage Alzheimer’s disease and reduce a key protein associated with the disease in the spinal fluid, in a small study published in the journal Lancet Neurology.
A new drug has been shown to improve the brain function of people with early stage Alzheimer’s disease and reduce a key protein associated with the disease in the spinal fluid, in a small study published in the journal Lancet Neurology.